ESR1 and invasive ductal breast carcinoma: Clinically, the majority of these tumors are invasive ductal carcinomas with a triple negative phenotype (lacking the estrogen receptor (ER) and progesterone receptor (PR), and do not overexpress the growth factor receptor Her2).